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SUMMARY. Chitosan is increasingly used as an alternative to synthetic polymers due to its water solubili-
ty, biodegradability, and biological activity. In this work, chitosan samples from three suppliers were eval-
uated and characterized by physicochemical methods in an attempt to analyze pharmaceutical applica-
tions. The degree of deacetylation (DD) was determined by 1H NMR, IR spectra, potentiometric titration,
and UV spectrophotometry. The analysis was supplemented by the techniques of DSC, TG, loss on drying,
pH of the suspension, heavy metals, sulphated ash, and triple detector size exclusion chromatography
(TriSEC). The use of UV, IR, and 1H NMR techniques to determine the degree of deacetylation, limit test-
ing for heavy metals and sulphated ash to analyze inorganic waste, and TriSEC to analyze molecular
weights and molecular distribution are recommended as basic requirements for pharmaceutical applica-
tions.
